{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:54:53Z","timestamp":1787583293696,"version":"build-2736575974"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000805","name":"European Centre for Disease Prevention and Control","doi-asserted-by":"publisher","award":["Framework contract number ECDC\/2019\/037"],"award-info":[{"award-number":["Framework contract number ECDC\/2019\/037"]}],"id":[{"id":"10.13039\/501100000805","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>This paper presents data on selected indicators to show progress towards elimination goals and targets for hepatitis B and hepatitis C in the 31 countries of the European Union (EU) and European Economic Area (EEA). A monitoring system was developed by the European Centre for Disease Prevention and Control, which combined newly collected data from EU\/EEA countries along with relevant data from existing sources. Data for 2017 were collected from the EU\/EEA countries via an online survey. All countries provided responses. In 2017, most countries reporting data had not reached prevention targets for childhood hepatitis B vaccination and for harm reduction services targeting people who inject drugs (PWID). Four of 12 countries had met the target for proportion of people living with chronic HBV diagnosed and seven of 16 met this target for hepatitis C. Data on diagnosed cases treated were lacking for hepatitis B. Of 12 countries reporting treatment data for hepatitis B, only Iceland met the target. This first collection of data across the EU\/EEA highlighted major issues with data completeness and quality and in the indicators that were used, which impairs a clear overview of progress towards the elimination of hepatitis. The available data, whilst incomplete, suggest that as of 2017, the majority of the EU\/EEA countries were far from meeting most of the 2020 targets, in particular those relating to harm reduction and diagnosis. It is critical to improve the data collected in order to develop more effective services for hepatitis prevention, diagnosis, and treatment that are needed in order to meet the 2030 elimination targets.<\/jats:p>","DOI":"10.1371\/journal.pgph.0000841","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T17:29:25Z","timestamp":1660757365000},"page":"e0000841","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Monitoring progress towards elimination of hepatitis B and C in the EU\/EEA"],"prefix":"10.1371","volume":"2","author":[{"given":"Katherine C.","family":"Sharrock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teymur","family":"Noori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Axelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Buti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8309-4270","authenticated-orcid":true,"given":"Asuncion","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1596-9880","authenticated-orcid":true,"given":"Olga","family":"Fursa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0099-272X","authenticated-orcid":true,"given":"Greet","family":"Hendrickx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Klavs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4024-677X","authenticated-orcid":true,"given":"Marko","family":"Korenjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojca","family":"Maticic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2275-5909","authenticated-orcid":true,"given":"Antons","family":"Mozalevskis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaela","family":"Rigoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6256-7809","authenticated-orcid":true,"given":"Magdalena","family":"Rosinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"Ruutel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Schatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Seyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Veldhuijzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Duffell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"key":"pgph.0000841.ref001","volume-title":"The Sustainable Development Goals","author":"United Nations (UN)"},{"issue":"14","key":"pgph.0000841.ref002","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1017\/S0950268817001947","article-title":"Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU\/EEA: a systematic review","volume":"145","author":"SHI Hofstraat","year":"2017","journal-title":"Epidemiology and infection"},{"issue":"9","key":"pgph.0000841.ref003","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/23744235.2020.1766104","article-title":"Mortality from liver diseases attributable to hepatitis B and C in the EU\/EEA\u2013descriptive analysis and estimation of 2015 baseline","volume":"52","author":"O M\u00e5rdh","year":"2020","journal-title":"Infectious Diseases"},{"key":"pgph.0000841.ref004","volume-title":"Global Health Sector Strategy on Viral Hepatitis 2016\u20132021","author":"World Health Organization (WHO)","year":"2016"},{"key":"pgph.0000841.ref005","unstructured":"World Health Organization Regional Office for Europe (WHO). Action plan for the health sector response to viral hepatitis in the WHO European Region Copenhagen: WHO; 2017 [cited 20 August, 2020]. https:\/\/www.euro.who.int\/en\/health-topics\/communicable-diseases\/hepatitis\/publications\/2017\/action-plan-for-the-health-sector-response-to-viral-hepatitis-in-the-who-european-region-2017."},{"key":"pgph.0000841.ref006","unstructured":"World Health Organization (WHO). Monitoring and evaluation for viral hepatitis B and C: recommended indicators and framework Geneva: WHO; 2016 [cited 20 August, 2020]. https:\/\/www.who.int\/hepatitis\/publications\/hep-b-c-monitoring-evaluation\/en\/."},{"key":"pgph.0000841.ref007","unstructured":"European Centre for Disease Prevention and Control (ECDC). Monitoring the responses to hepatitis B and C epidemics in the EU\/EEA Member States, 2019 Stockholm: ECDC; 2020 [cited 24 February, 2020]. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/monitoring-responses-hepatitis-b-and-c-epidemics-eueea-member-states-2019."},{"issue":"10268","key":"pgph.0000841.ref008","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0140-6736(20)32642-8","article-title":"The COVID-19 vaccines rush: participatory community engagement matters more than ever","volume":"397","author":"RA Burgess","year":"2021","journal-title":"The Lancet"},{"key":"pgph.0000841.ref009","unstructured":"World Health Organization (WHO). Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) Geneva: WHO; [cited 5 May, 2021]. https:\/\/www.who.int\/data\/maternal-newborn-child-adolescent-ageing\/indicator-explorer-new\/mca\/hepatitis-b-(hepb3)-immunization-coverage-among-1-year-olds-(-)."},{"key":"pgph.0000841.ref010","unstructured":"World Health Organization (WHO). WHO vaccine-preventable diseases: monitoring system 2020 global summary (15-Jul 2020) Geneva: WHO; [cited 24 February, 2021]. https:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/timeseries\/tswucoveragehepb3.html."},{"key":"pgph.0000841.ref011","unstructured":"European Centre for Disease Prevention and Control (ECDC). Vaccine Scheduler: Hepatitis B: Recommended vaccinations: ECDC; [cited 24 February, 2020]. https:\/\/vaccine-schedule.ecdc.europa.eu\/Scheduler\/ByDisease?SelectedDiseaseId=6&SelectedCountryIdByDisease=-1."},{"key":"pgph.0000841.ref012","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Monitoring the elimination of viral hepatitis as a public health threat among people who inject drugs in Europe: the elimination barometer. Luxembourg: EMCDDA; 2019 [cited 24 February 2021]. https:\/\/www.emcdda.europa.eu\/technical-reports\/monitoring-the-elimination-of-viral-hepatitis-as-a-public-health-threat-among-people-who-inject-drugs-in-Europe_en."},{"issue":"1","key":"pgph.0000841.ref013","doi-asserted-by":"crossref","first-page":"e004275","DOI":"10.1136\/bmjgh-2020-004275","article-title":"The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection","volume":"6","author":"CM Pley","year":"2021","journal-title":"BMJ Global Health"},{"issue":"3","key":"pgph.0000841.ref014","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3390\/ijerph18030988","article-title":"The Impact of the COVID-19 Pandemic on Immunization Campaigns and Programs: A Systematic Review","volume":"18","author":"ZS Lassi","year":"2021","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"pgph.0000841.ref015","unstructured":"European Centre for Disease Prevention and Control (ECDC). Hepatitis B\u2014Annual Epidemiological Report for 2018 Stockholm: ECDC; 2020 [cited 24 February 2021]. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/hepatitis-b-annual-epidemiological-report-2018."},{"key":"pgph.0000841.ref016","unstructured":"European Centre for Disease Prevention and Control (ECDC). Hepatitis C\u2014Annual Epidemiological Report for 2018 Stockholm: ECDC; 2020 [cited 24 February 2021]. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/hepatitis-c-annual-epidemiological-report-2018."},{"key":"pgph.0000841.ref017","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12954-020-00439-3","article-title":"The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries","volume":"17","author":"M. Maticic","year":"2020","journal-title":"Harm Reduct J"},{"key":"pgph.0000841.ref018","unstructured":"Stone K, Shirley-Beavan S. Global State of Harm Reduction 2018. London: Harm Reduction International; [24 February 2021]. https:\/\/www.hri.global\/files\/2019\/02\/05\/global-state-harm-reduction-2018.pdf."},{"issue":"6","key":"pgph.0000841.ref019","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/QCO.0000000000000216","article-title":"Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence","volume":"28","author":"M Hickman","year":"2015","journal-title":"Current opinion in infectious diseases"},{"issue":"2","key":"pgph.0000841.ref020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S2468-1253(17)30284-4","article-title":"Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe","volume":"3","author":"AD Marshall","year":"2018","journal-title":"The lancet Gastroenterology & hepatology"},{"key":"pgph.0000841.ref021","unstructured":"Rigoni, R, Tammi, T, van der Gouwe, D, Oberzil, V; Csak R, Schatz, E. (2021) Civil Society Monitoring of Harm Reduction in Europe, 2020. Executive Summary. Amsterdam, Correlation\u2013European Harm Reduction Network. https:\/\/www.correlation-net.org\/wp-content\/uploads\/2021\/03\/monitoring_report2020.pdf."},{"key":"pgph.0000841.ref022","unstructured":"EMCDDA trendspotter briefing\u2014Impact of COVID-19 on drug services and help-seeking in Europe. 2020. https:\/\/www.emcdda.europa.eu\/publications\/ad-hoc\/impact-of-covid-19-on-drug-services-and-help-seeking-in-europe_en."},{"issue":"1","key":"pgph.0000841.ref023","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12954-020-00432-w","article-title":"The impact of the COVID-19 pandemic on harm reduction services in Spain","volume":"17","author":"CA Picchio","year":"2020","journal-title":"Harm Reduction Journal"},{"key":"pgph.0000841.ref024","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European Drug Report 2020: Trends and Developments Luxembourg: EMCDDA; [cited 24 February 2021]. https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/13236\/TDAT20001ENN_web.pdf."},{"key":"pgph.0000841.ref025","unstructured":"Hepatitis C testing and treatment interventions for the homeless population in London during the Covid-19 pandemic: Outcomes and learning. 2020. http:\/\/ljwg.org.uk\/wp-content\/uploads\/2021\/01\/HCV-testing-in-temporary-accommodation-during-lockdown-December-2020.pdf."},{"issue":"11","key":"pgph.0000841.ref026","doi-asserted-by":"crossref","first-page":"e0207037","DOI":"10.1371\/journal.pone.0207037","article-title":"Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country","volume":"13","author":"AWM Suijkerbuijk","year":"2018","journal-title":"PloS one"},{"key":"pgph.0000841.ref027","doi-asserted-by":"crossref","first-page":"103394","DOI":"10.1016\/j.drugpo.2021.103394","article-title":"Cost-effectiveness of mass screening for Hepatitis C virus among all inmates in an Irish prison","author":"Z Ward","year":"2021","journal-title":"International Journal of Drug Policy"},{"issue":"8","key":"pgph.0000841.ref028","doi-asserted-by":"crossref","first-page":"e003153","DOI":"10.1136\/bmjopen-2013-003153","article-title":"Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons","volume":"3","author":"NK Martin","year":"2013","journal-title":"BMJ Open"},{"issue":"1","key":"pgph.0000841.ref029","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12954-019-0313-7","article-title":"Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners","volume":"16","author":"D Crowley","year":"2019","journal-title":"Harm Reduction Journal"},{"key":"pgph.0000841.ref030","unstructured":"European Centre for Disease Prevention and Control (ECDC). Hepatitis B and C testing activities, needs, and priorities in the EU\/EEA Stockholm: ECDC; 2017 [cited 20 August, 2020]. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/hepatitis-b-and-c-testing-activities-needs-and-priorities-eueea."},{"key":"pgph.0000841.ref031","unstructured":"European Centre for Disease Prevention and Control (ECDC). Hepatitis B and C testing strategies in healthcare and community settings in the EU\/EEA Stockholm: ECDC; 2018 [cited 20 August, 2020]. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/hepatitis-b-and-c-testing-strategies-healthcare-and-community-settings-eueea."},{"issue":"Supplement_5","key":"pgph.0000841.ref032","doi-asserted-by":"crossref","first-page":"v17","DOI":"10.1093\/jac\/dkz452","article-title":"From peer-based to peer-led: redefining the role of peers across the hepatitis C care pathway: HepCare Europe","volume":"74","author":"J Surey","year":"2019","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"pgph.0000841.ref033","unstructured":"European Centre for Disease Prevention and Control (ECDC). Public health guidance on HIV, hepatitis B and C testing in the EU\/EEA\u2013An integrated approach. Stockholm: ECDC; 2018 [cited 20 August, 2020]. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/public-health-guidance-hiv-hepatitis-b-and-c-testing-eueea."},{"key":"pgph.0000841.ref034","unstructured":"European Centre for Disease Prevention and Control (ECDC). Technical protocol for hepatitis C prevalence surveys in the general population Stockholm: ECDC; [cited 02\/07\/2021]. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/hepatitis-C-prevalence-surveys-technical-protocol.pdf."},{"issue":"5","key":"pgph.0000841.ref035","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: Final update of the series(\u2606)","volume":"73","year":"2020","journal-title":"Journal of hepatology"},{"issue":"2","key":"pgph.0000841.ref036","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"Journal of hepatology"},{"issue":"5","key":"pgph.0000841.ref037","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: Final update of the series","volume":"73","author":"J-M Pawlotsky","year":"2020","journal-title":"Journal of hepatology"},{"issue":"10","key":"pgph.0000841.ref038","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1111\/liv.14222","article-title":"Innovative strategies for the elimination of viral hepatitis at a national level: A country case series","volume":"39","author":"SE Schr\u00f6eder","year":"2019","journal-title":"Liver International"},{"key":"pgph.0000841.ref039","unstructured":"European Centre for Disease Prevention and Control (ECDC). Monitoring implementation of the Dublin Declaration Stockholm: ECDC; [cited 02\/07\/2021]. https:\/\/www.ecdc.europa.eu\/en\/all-topics-zhiv-infection-and-aidsprevention-and-control\/monitoring-implementation-dublin."},{"key":"pgph.0000841.ref040","volume-title":"Interim guidance for country validation of viral hepatitis elimination, N.A.C","author":"World Health Organization","year":"2021"}],"updated-by":[{"DOI":"10.1371\/journal.pgph.0001907","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000}}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0000841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T17:29:58Z","timestamp":1660757398000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0000841"}},"subtitle":[],"editor":[{"given":"Larissa","family":"Otero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0000841","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pgph.0001907","asserted-by":"object"}]},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,17]]}}}